Pregnancy outcomes in women receiving growth hormone replacement therapy enrolled in the NordiNet® International Outcome Study (IOS) and the American Norditropin® Studies: Web-Enabled Research (ANSWER) Program

PURPOSE: Data on the safety of growth hormone (GH) replacement therapy during pregnancy are limited. We report a combined analysis of data from pregnant women treated with GH while enrolled in two non-interventional, multicenter studies: NordiNet® International Outcome Study (IOS) and the American N...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Pituitary
Hlavní autoři: Biller, Beverly M. K., Höybye, Charlotte, Carroll, Paul, Gordon, Murray B., Birkegård, Anna Camilla, Kelepouris, Nicky, Nedjatian, Navid, Weber, Matthias M.
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer US 2021
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8270875/
https://ncbi.nlm.nih.gov/pubmed/33709288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11102-021-01138-3
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky